[Research progress in the application of ivabradine in children with cardiovascular diseases]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiJiang L.
europepmc +1 more source
[Efficacy and safety of venetoclax combined with tyrosine kinase inhibitors and reduced-dose chemotherapy in 13 cases of minimal residual disease-positive and relapsed/refractory Ph(+) acute lymphoblastic leukemia]. [PDF]
Zhonghua Xue Ye Xue Za ZhiAi H, Liang TT, Wang Q, Wu HF, Yin QS.
europepmc +1 more source
[Expert consensus on the clinical application of oral antihistamines in the treatment of upper airway allergic diseases in children]. [PDF]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za ZhiXu Z.
europepmc +1 more source
[Mechanistic research progress on radiotherapy resistance of cancer stem cells]. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanLuo Z, Yu M, Li J, Zhang S, Shen T.
europepmc +1 more source
[EVA1A overexpression improves non-alcoholic fatty liver disease in mice by regulating lipid metabolism and promoting lipophagy]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoXu J +8 more
europepmc +1 more source
[Clinical characteristics and survival outcomes of patients with immunoglobulin A multiple myeloma in the bortezomib era: A single-center retrospective cohort study]. [PDF]
Zhonghua Xue Ye Xue Za ZhiGao F +5 more
europepmc +1 more source
[Chinese expert consensus on standard procedures for the outpatient management of patients with multiple myeloma (2025)]. [PDF]
Zhonghua Xue Ye Xue Za ZhiPlasma Cell Disease Group +3 more
europepmc +1 more source
[The peptide toxin components and nucleotide metabolites in <i>Macrothele raveni</i> venom synergistically inhibit cancer cell proliferation by activating the pro-apoptotic pathways]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoXie T, Wang Y, Guo T, Yuan C.
europepmc +1 more source